Brief: Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Product
Dec 12 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST: SAID ON THURSDAY SECURES PARTNERSHIP WITH BIOCONNECTION FOR PRODUCTION OF DRUG PRODUCT DRUG PRODUCT PROCESS PERFORMANCE QUALIFICATION PROGRAMME TO BE CONDUCTED AT BIOCONNECTION’S MANUFACTURING FACILITY IN OSS, THE NETHERLANDS Source text for Workspace: nMFN45kFLv Further company coverage: [IBTb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln
Brief: Infant Bacterial Therapeutics Q4 Operating Loss Narrows To SEK 20.54 Mln
Brief: Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Product
Brief: Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Substance